Arena Pharmaceuticals, Inc. (ARNA) News
Filter ARNA News Items
ARNA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ARNA News Highlights
- ARNA's 30 day story count now stands at 12.
- Over the past 23 days, the trend for ARNA's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about ARNA are BHP and GOLD.
Latest ARNA News From Around the Web
Below are the latest news stories about Arena Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARNA as an investment opportunity.
Arena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31Arena Pharmaceuticals press release (NASDAQ:ARNA): Q4 GAAP EPS of -$2.54 misses by $0.31. Cash, cash equivalents and marketable securities were $0.7B at December 31, 2021 as compared to $1.1B at December 31, 2020... |
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program UpdatesPARK CITY, Utah, February 23, 2022--Arena Pharmaceuticals today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021 |
SFO opens criminal probe into collapse of Arena TelevisionThe Serious Fraud Office has opened a criminal investigation into Arena Television, a collapsed broadcaster that worked on the Euro 2020 football tournament and Glastonbury. |
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PARK CITY, Utah, February 17, 2022--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 18 new employees 18,527 inducement restricted stock units ("RSUs"). The inducement RSUs have a grant date and vesting commencement date of February 15, 2022 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4). |
Top Merger Stocks Held By Fund Managers, Mid-Q1 2022Each quarter, I spend some time reading Form 13F filings from hedge funds that specialize in merger arbitrage, documenting, and then analyzing which M&A stocks the funds have bought and which ones they haven't. I then compile the top 10 stocks held in these funds and share the results with... |
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23PARK CITY, Utah, February 09, 2022--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2021 financial results and provide a corporate update on Wednesday, February 23, 2022, after the close of the U.S. financial markets. |
Alpine Associates Management Inc. Buys Cerner Corp, Kirkland Lake Gold, Rogers Corp, Sells , ,Englewood Cliffs, NJ, based Investment company Alpine Associates Management Inc. (Current Portfolio) buys Cerner Corp, Kirkland Lake Gold, Rogers Corp, CyrusOne Inc, Arena Pharmaceuticals Inc, sells , , , Five9 Inc, Covanta Holding Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Alpine Associates Management Inc.. |
Versor Investments LP Buys Cerner Corp, Ortho Clinical Diagnostics Holdings PLC, Vonage ...Investment company Versor Investments LP (Current Portfolio) buys Cerner Corp, Ortho Clinical Diagnostics Holdings PLC, Vonage Holdings Corp, Umpqua Holdings Corp, Rogers Corp, sells Five9 Inc, , , , during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Versor Investments LP. |
Did The Smart Money Play Arena Pharmaceuticals, Inc. (ARNA) Correctly?The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of September 30th, when the S&P 500 Index was trading around the […] |
Integral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories, ...Investment company Integral Health Asset Management, LLC (Current Portfolio) buys McKesson Corp, Centene Corp, Abbott Laboratories, Biogen Inc, Amedisys Inc, sells Arena Pharmaceuticals Inc, Medtronic PLC, Hologic Inc, Zimmer Biomet Holdings Inc, Acadia Healthcare Co Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Integral Health Asset Management, LLC. |